Top > Products/Pipeline

Products and Pipeline




1. Approved Drug
F647
Indication : Idiopathic Pulmonary Fibrosis

2. In Clinical Development
F647: Phase II
Indication : Radiation-induced Pneumonitis



F351: Phase I
 Indication: Liver Fibrosis/Cirrhosis

3. In pre-IND development

F573
Acute liver failure/ Acute-on-chronic liver failure